519 672 2121
Close mobile menu
Showing 441 - 450 of 1595
Published on: 1 Nov 2023 By ,

Class Action pursued for Canadians alleging harms from Ozempic, semaglutide drugs

Ozempic, the popular drug approved in Canada to treat diabetes, has been linked to serious harms to users. Studies have shown a link between the use of semaglutide โ€“ the active ingredient in Ozempic โ€“ and an increased risk of severe gallbladder-related harms, including gallstones, and gastrointestinal issues, including โ€œstomach paralysisโ€ and intestinal blockages. Despite...

Continue reading the post titled Class Action pursued for Canadians alleging harms from Ozempic, semaglutide drugs
Published on: 22 Apr 2011 By (Dianne Saxe)

Highly Commended – Top Tier – 2011

Dear Readers, Thank you for continuing to vote us one of your most honoured firms. We have received another commendation: “Your firm is receiving this notification as a recipient in the InterContinental Finance Magazineโ€™s โ€˜HIGHLY COMMENDED โ€“ TOP TIER FIRMS – 2011โ€™ programme.ย Your firm is considered to have performed to exceptional levels during one of...

Continue reading the post titled Highly Commended – Top Tier – 2011
Published on: 25 Jul 2023 By

Xeljanz, linked to heart attacks, blood clots, and cancers โ€“ is now approved to treat arthritis of the spine

Xeljanz, an arthritis drug that has been the subject of multiple Health Canada advisories due to its potential to expose users to serious health risks (including heart attack, cancer, and death), has now been approved for use to treat a new type of chronic health condition: ankylosing spondylitis. Xeljanz is an arthritis drug prescribed for...

Continue reading the post titled Xeljanz, linked to heart attacks, blood clots, and cancers โ€“ is now approved to treat arthritis of the spine
Published on: 2 Apr 2024 By

Privacy pulse: A series on data governance

As a business owner or professional, you may be experiencing challenges navigating privacy laws throughout various jurisdictions, protecting personal and confidential information, and understanding the risks associated with non-compliance. As a Certified Information Privacy Professional in Canada and the United States, I frequently receive requests on how businesses can simply keep up with this rapidly...

Continue reading the post titled Privacy pulse: A series on data governance
Published on: 16 Apr 2010 By (Dianne Saxe)

Reg. 153/04 changes: impacts on contaminated sites?

Reg. 153/04- changes to rules on contaminated sites Working on contaminated sites? Dianne gave a presentation this week on Reg. 153/04, and the amendments made by 511/09. They mean big changes for people working on sites in Ontario, especially re: tougher cleanup standards; better investigations; and more Ministry of the Environment supervision. Click above for...

Continue reading the post titled Reg. 153/04 changes: impacts on contaminated sites?

Terms of Use

Your access to and use of any material on this Website constitutes your acceptance of, and is conditional upon your acceptance of and compliance with, all of the following terms and conditions. If you do not agree with any of these terms or conditions, do not access or use this Website. YOU ACKNOWLEDGE THAT SISKINDS...

Continue reading the post titled Terms of Use
Published on: 7 May 2009 By (Dianne Saxe)

Green energy and condominiums

Should the Condominium Act be amended to encourage developers to include green energy and energy conservation in condominium projects? This was the subject of a fascinating and passionate exchange between members of the Ontario Bar Association’s Real Property Section, which some of you will enjoy reading: ย  Dear Chris, Further to our conference call yesterday...

Continue reading the post titled Green energy and condominiums